OPKO Health, Inc. Paid-in-Kind Interest
OPKO Health, Inc. (OPK) reported Paid-in-Kind Interest of $4.98 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-28
- OPKO Health, Inc. paid-in-kind interest for the quarter ending 2026-06-30 was $2.55M, a 95.52% decline year-over-year.
- OPKO Health, Inc. paid-in-kind interest for the quarter ending 2026-03-31 was $2.43M, a 47.67% decline year-over-year.
- OPKO Health, Inc. paid-in-kind interest for the quarter ending 2025-12-31 was $2.39M, a 50.13% decline year-over-year.
- OPKO Health, Inc. paid-in-kind interest for the quarter ending 2025-09-30 was $2.31M, a 49.97% decline year-over-year.
- OPKO Health, Inc. paid-in-kind interest for fiscal 2025 was $66.26M, a 277.60% increase from fiscal 2024.
- OPKO Health, Inc. paid-in-kind interest for fiscal 2024 was $17.55M, a 538.07% increase from fiscal 2023.
- OPKO Health, Inc. paid-in-kind interest for fiscal 2023 was $2.75M, a 0.00% change from fiscal 2022.
- OPKO Health, Inc. paid-in-kind interest for fiscal 2022 was $2.75M, a 70.71% decline from fiscal 2021.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.55M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $4.98M 10-Q/A · filed 2026-08-28 | $7.37M derived: sum of 3 quarters · filed 2026-08-28 | $9.68M derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $2.43M 10-Q/A · filed 2026-08-28 | $4.82M derived: sum of 2 quarters · filed 2026-08-28 | $7.13M derived: sum of 3 quarters · filed 2026-08-28 | $64.04M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.70M derived: sum of 2 quarters · filed 2026-02-26 | $61.61M derived: sum of 3 quarters · filed 2026-08-28 | $66.26M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.31M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $59.22M derived: sum of 2 quarters · filed 2026-08-28 | $63.87M 10-Q · filed 2025-10-29 | $68.66M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $56.91M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $61.56M 10-Q/A · filed 2026-08-28 | $66.35M derived: sum of 3 quarters · filed 2026-08-28 | $70.97M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $4.65M 10-Q/A · filed 2026-08-28 | $9.44M derived: sum of 2 quarters · filed 2026-08-28 | $14.06M derived: sum of 3 quarters · filed 2026-08-28 | $18.35M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.41M derived: sum of 2 quarters · filed 2026-02-26 | $13.70M derived: sum of 3 quarters · filed 2026-02-26 | $17.55M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $8.91M derived: sum of 2 quarters · filed 2025-10-29 | $12.75M 10-Q · filed 2025-10-29 | $13.45M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $8.14M 10-Q · filed 2025-07-31 | $8.83M derived: sum of 3 quarters · filed 2026-02-26 | $9.52M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $3.84M 10-Q · filed 2025-05-01 | $4.54M derived: sum of 2 quarters · filed 2026-02-26 | $5.23M derived: sum of 3 quarters · filed 2026-02-26 | $5.92M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.39M derived: sum of 2 quarters · filed 2026-02-26 | $2.07M derived: sum of 3 quarters · filed 2026-02-26 | $2.75M 10-K · filed 2026-02-26 |
| 2023-09-30 | $693.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.38M derived: sum of 2 quarters · filed 2024-11-07 | $2.06M 10-Q · filed 2024-11-07 | $2.75M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.36M 10-Q · filed 2024-08-07 | $2.06M derived: sum of 3 quarters · filed 2025-03-03 | $2.75M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $678.00K 10-Q · filed 2024-05-07 | $1.37M derived: sum of 2 quarters · filed 2025-03-03 | $2.06M derived: sum of 3 quarters · filed 2025-03-03 | $2.75M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.39M derived: sum of 2 quarters · filed 2025-03-03 | $2.07M derived: sum of 3 quarters · filed 2025-03-03 | $2.75M 10-K · filed 2025-03-03 |
| 2022-09-30 | $693.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.38M derived: sum of 2 quarters · filed 2023-11-06 | $2.06M 10-Q · filed 2023-11-06 | $4.28M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.36M 10-Q · filed 2023-08-03 | $3.59M derived: sum of 3 quarters · filed 2024-03-01 | $5.77M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | $678.00K 10-Q · filed 2023-05-03 | $2.90M derived: sum of 2 quarters · filed 2024-03-01 | $5.09M derived: sum of 3 quarters · filed 2024-03-01 | $7.48M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $4.41M derived: sum of 2 quarters · filed 2024-03-01 | $6.80M derived: sum of 3 quarters · filed 2024-03-01 | $9.39M 10-K · filed 2024-03-01 |
| 2021-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.58M derived: sum of 2 quarters · filed 2022-11-08 | $7.16M 10-Q · filed 2022-11-08 | $9.52M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.98M 10-Q · filed 2022-08-04 | $7.34M derived: sum of 3 quarters · filed 2023-02-27 | $9.95M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $2.58M 10-Q · filed 2022-05-09 | $4.94M derived: sum of 2 quarters · filed 2023-02-27 | $7.56M derived: sum of 3 quarters · filed 2023-02-27 | $10.10M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.97M derived: sum of 2 quarters · filed 2023-02-27 | $7.51M derived: sum of 3 quarters · filed 2023-02-27 | $9.99M 10-K · filed 2023-02-27 |
| 2020-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $5.16M derived: sum of 2 quarters · filed 2021-10-28 | $7.64M 10-Q · filed 2021-10-28 | $11.81M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $5.02M 10-Q · filed 2021-07-29 | $9.20M derived: sum of 3 quarters · filed 2022-03-01 | $10.88M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.48M 10-Q · filed 2021-04-28 | $6.66M derived: sum of 2 quarters · filed 2022-03-01 | $8.35M derived: sum of 3 quarters · filed 2022-03-01 | $8.20M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.86M derived: sum of 2 quarters · filed 2022-03-01 | $5.72M derived: sum of 3 quarters · filed 2022-03-01 | $8.73M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.55M derived: sum of 2 quarters · filed 2020-10-29 | $4.56M 10-Q · filed 2020-10-29 | $5.90M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $2.87M 10-Q · filed 2020-07-31 | $4.21M derived: sum of 3 quarters · filed 2021-02-18 | $5.57M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $3.01M 10-Q · filed 2020-05-06 | $4.35M derived: sum of 2 quarters · filed 2021-02-18 | $5.71M derived: sum of 3 quarters · filed 2021-02-18 | $7.07M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $2.71M derived: sum of 2 quarters · filed 2021-02-18 | $4.06M derived: sum of 3 quarters · filed 2021-02-18 | $4.90M 10-K · filed 2021-02-18 |
| 2018-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.72M derived: sum of 2 quarters · filed 2019-11-05 | $3.56M 10-Q · filed 2019-11-05 | $4.19M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.20M 10-Q · filed 2019-08-07 | $2.83M derived: sum of 3 quarters · filed 2020-03-02 | $3.48M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $843.00K 10-Q · filed 2019-05-08 | $1.47M derived: sum of 2 quarters · filed 2020-03-02 | $2.12M derived: sum of 3 quarters · filed 2020-03-02 | $2.78M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.28M derived: sum of 2 quarters · filed 2020-03-02 | $1.94M derived: sum of 3 quarters · filed 2020-03-02 | $2.58M 10-K · filed 2020-03-02 |
| 2017-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.30M derived: sum of 2 quarters · filed 2018-11-09 | $1.94M 10-Q · filed 2018-11-09 | $2.58M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $654.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.29M 10-Q · filed 2018-08-07 | $1.93M derived: sum of 3 quarters · filed 2019-03-01 | $2.58M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $640.00K 10-Q · filed 2018-05-08 | $1.28M derived: sum of 2 quarters · filed 2019-03-01 | $1.93M derived: sum of 3 quarters · filed 2019-03-01 | $2.59M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.29M derived: sum of 2 quarters · filed 2019-03-01 | $1.95M derived: sum of 3 quarters · filed 2019-03-01 | $2.70M 10-K · filed 2019-03-01 |
| 2016-09-30 | $655.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.31M derived: sum of 2 quarters · filed 2017-11-08 | $2.06M 10-Q · filed 2017-11-08 | $2.50M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.41M 10-Q · filed 2017-08-08 | $1.84M derived: sum of 3 quarters · filed 2019-01-29 | $2.34M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | $749.00K 10-Q · filed 2017-05-10 | $1.19M derived: sum of 2 quarters · filed 2019-01-29 | $1.68M derived: sum of 3 quarters · filed 2019-01-29 | $2.31M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | $436.00K derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $931.00K derived: sum of 2 quarters · filed 2019-01-29 | $1.56M derived: sum of 3 quarters · filed 2019-01-29 | $2.61M 8-K · filed 2019-01-29 |
| 2015-09-30 | $495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.12M derived: sum of 2 quarters · filed 2016-11-07 | $2.18M 10-Q · filed 2016-11-07 | $3.24M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $625.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.68M 10-Q · filed 2016-08-08 | $2.75M derived: sum of 3 quarters · filed 2017-03-01 | $3.79M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.06M 10-Q · filed 2016-05-09 | $2.12M derived: sum of 2 quarters · filed 2017-03-01 | $3.16M derived: sum of 3 quarters · filed 2017-03-01 | $4.94M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.10M derived: sum of 2 quarters · filed 2017-03-01 | $3.88M derived: sum of 3 quarters · filed 2017-03-01 | $5.66M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.82M derived: sum of 2 quarters · filed 2015-11-09 | $4.60M 10-Q · filed 2015-11-09 | $6.33M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.56M 10-Q · filed 2015-08-05 | $5.29M derived: sum of 3 quarters · filed 2016-02-29 | $6.42M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.78M 10-Q · filed 2015-05-11 | $3.51M derived: sum of 2 quarters · filed 2016-02-29 | $4.64M derived: sum of 3 quarters · filed 2016-02-29 | $6.45M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.86M derived: sum of 2 quarters · filed 2016-02-29 | $4.68M derived: sum of 3 quarters · filed 2016-02-29 | $5.98M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.95M derived: sum of 2 quarters · filed 2014-11-07 | $4.25M 10-Q · filed 2014-11-07 | $4.25M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $3.12M 10-Q · filed 2014-08-11 | $3.12M derived: sum of 3 quarters · filed 2015-02-27 | $3.12M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $1.30M 10-Q · filed 2014-05-09 | $1.30M derived: sum of 2 quarters · filed 2015-02-27 | $1.30M derived: sum of 3 quarters · filed 2015-02-27 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $0.00 10-K · filed 2015-02-27 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | |||
| 2011-12-31 | $2.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |